Role of parathyroid hormone-related peptide in the pathogenesis of pituitary adenomas

Frontiers of Hormone Research

Volumn 20, Issue , 1996, Pages 137-155

  Yamashita, Shunichi ^a   Akino, Kozo ^a   Ohtsuru, Akira ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 8244237324     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (84)

1. Molitch ME: Neuroendocrinology, in Felig P, Baxter JD, Frohman LA (eds): Endocrinology and Metabolism, ed 3. New York, McGraw-Hill. 1995, pp 221-288.
2. Melmed S: Pathogenesis of pituitary tumors: in Levine AJ, Schimdek HH (eds): Molecular Genetics of Nervous System Tumors. New York, Wiley-Liss, 1993, pp 255-263.
3. Jones TH, Kennedy RL: Cytokines and hypothalamic-pituitary function. Cytokine 1993;5:531-538.
4. Spada A, Vallar L, Faglia G: Cellular alterations in pituitary tumors. Eur J Endocrinol 1994;130:43-52.
5. Halper J, Parnell PG, Carter BJ, Ren P: Scheithauer BW: Presence of growth factors in human pituitary. Lab Invest 1992;66:639-645.
6. Gonsky R, Herman V, Melmed S, Fagin JA: Transforming DNA sequences present in human prolactin-secreting pituitary tumors. Mol Endocrinol 1991;5:1687-1695.
7. Velkoniers B, Vergani P, Trouillas J, D'Haes J, Hooghe RJ, Hooghe-Peters EL: Expression of IL-6 mRNA in normal rat and human pituitarics and in human pituitary adenomas. J Histochem Cytochem 1994;42:67-76.
8. Ezzat S, Melmed S: The role of growth factors in the pituitary. J Endocrinol Invest 1990;13:320-326.
9. Webster J, Ham J, Bevan JS, TenHorn CD, Scanlon MF: Preliminary characterization of growth factors secreted by human pituitary tumors. J Clin Endocrinol Metab 1991;72:687-692.
10. Melmed S, Herman-Bonert V, Prager D, Yamasaki H, Gonsky R, Fagin JA: Role of growth factors in regulation of pituitary hormone production and in the pathogenesis of pituitary tumors; in Faglia G, Beck-Peccoz P, Ambrosi B, Travaglini P, Spada A (eds): Pituitary Adenomas: New Trends in Basic and Clinical Research. Amsterdam, Elsevier, 1991, pp 123-130.
11. Elias KA, Weiner RI: Direct arterial vascularization of estrogen induced prolactin secreting anterior pituitary tumor. Proc Natl Acad Sci USA 1984;81:4549-4553.
12. Folkman J: The role of angiogenesis in tumor growth. Sem Cancer Biol 1992;3:65-71.
13. Amizuka N, Warshawsky H, Henderson JE, Goltzman D, Karaplis AC: Parathyroid hormone-related peptide-deleted mice show abnormal epiphyseal cartilage development and altered endochondrial bone formation. J Cell Biol 1994;126:1611-1623.
14. Maseley JM, Kubota M, Diefenbach JH, et al: Parathyroid hormone-related protein purified from a human lung cancer cell line. Proc Natl Acad Sci USA 1987;84:5048-5053.
15. Suva LJ, Winslow GA, Weltenhall RE, et al: A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 1987;237:893-896.
16. Strewler GJ, Stern PH, Jacobs JW, Eveloff J, Klein RF, Leung SC, Rosenblatt M, Nissenson RA: Parathyroid hormone like protein from human renal carcinoma cells. J Clin Invest 1987;80:1803-1807.
17. Campos RV, Asa SL, Drucher DJ: Immunohistochemical localization of parathyroid hormone-like peptide in rat fetus. Cancer Res 1991;51:6351-6357.
18. Margin J, Ikeda K, Dreyer BE, Broadus AE: Isolation and characterization of the human parathyroid hormone-like peptide gene. Proc Natl Acad Sci USA 1989;86:2408-2412.
19. Urena P, Kong XF, Abou-Samra A, Juppner H, Kronengerg HM, Potts JT, Segre GV: parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acids are widely distributed in rat tissues. Endocrinology 1993;133:617-623.
20. Ikeda K, Weir EC, Mangin N, Dannies PS, Kinder B, Deftos LJ, Brown EM, Broadus AE: Expression of messenger ribonucleic acids encoding a parathyroid hormone-like peptide in normal human and animal tissues with abnormal expression in human parathyroid adenomas. Mol Endocrinol 1988;2:1230-1236.
21. Asa SL, Henderson J, Goltzman D, Drucker DJ: Parathyroid hormone-like peptide in normal and endocrine tissues. J Clin Endocrinol Metab 1990;71:1112-1118.
22. Ito M, Enomoto H, Usa T, Villadolid MC, Ohtsuru A, Namba H, Sekine I, Yamashita S: Expression of parathyroid hormone-related peptide in human pituitary tumors. J Clin Pathol 1993;48:682-683.
23. Nakashima M, Ohtsuru A, Enomoto H, Lou W, Nakayama T, Ito M, Izumi M, Sekine I, Nagataki S, Yamashita S: Expression of parathyroid hormone-related hormone (PTHrP) in human thyroid tumors. J Pathol 1995;175:227-233.
24. Yamashita S, Izumi M, Nagataki S: Acromegaly and pituitary carcinoma. Ann Intern Med 1992;117:1057-1058.
25. Vargas SJ, Gillespie MT, Powell GJ, Southby J, Danks JA, Moseley JM, Martin TJ: Localization of parathyroid hormone-related protein mRNA expression in breast cancer and metastatic lesions by in situ hybridization. J Bone Miner Res 1992;7:971-979.
26. Matsushita H, Hara M, Nakazawa H, Shishiba Y, Matsuhashi T: The presence of immunoreactive parathyroid hormone-related protein in parathyroid adenoma cells. Acta Pathol Jpn 1992;42:35-41.
27. Mune T, Katakami H, Kato Y, Yasuda K, Matsukura S, Miura K: Production and secretion of parathyroid hormone-related protein in phcochromocytoma: Participation of an alpha-adrenergic mechanism. J Clin Endocrinol Metab 1993;76:757-762.
28. Liapis H, Crouch EC, Grosso LE, Kitazawa S, Wick MR: Expression of parathyroid like protein in normal, proliferative, and neoplastic human breast tissues. Am J Pathol 1993;143:1169-1178.
29. Iwamura M, di Sant'Agnese P, Wu G: Immunohistochemical localization of parathyroid hormone-related protein in human prostate cancer. Cancer Res 1993;58:1724-1726.
30. Matias GX, Prat J, Young RH, Capen CC, Rosel TJ, Delellis RA, Scully RE: Human parathyroid hormone-related protein in ovarian small cell carcinoma. An immunohistochemical study. Cancer 1994;73:1878-1881.
31. Gotoh A, Kitazawa S, Mizuno Y, Takenaka A, Arakawa S, Matsumoto O, Kitazawa R, Fujimori T, Maeda S, Kamidono S: Common expression of parathyroid hormone-related protein and no correlation of calcium level in renal cell carcinomas. Cancer 1993;71:2803-2806.
32. Kitazawa S, Fukase M, Kitazawa R, Takenaka A, Gotoh A, Fujita T, Maeda S: Immunohistologic evaluation of parathyroid hormone-related protein in human lung cancer and normal tissue with newly developed monoclonal antibody. Cancer 1991;67:984-989.
33. Dunne FP, Rollason T, Ratcliffe WA, Marshall T, Health DA: Parathyroid hormone-related protein gene expression in invasive cervical tumors. Cancer 1994;74:83-89.
34. Yamamura IY, Kitazawa S, Kitazawa R, Fujimori T, Chiba T, Maeda S: Parathyroid hormone-related protein in gastric cancers with heterotopic ossification. Cancer 1993;72:83-89.
35. Roskams T, Willems M, Campos RV, Drucker DJ, Yap SH, Desmet VJ: Parathyroid hormone-related peptide expression in primary and metastatic liver tumors. Histopathol 1993;23:519-525.
36. Martin TJ, Moseley JM, Gillespie MT: Parathyroid hormone-related protein: Biochemistry and molecular biology. Clin Rev Biochem Mol Biol 1991;26:377-395.
37. Tashijian AJ Jr: Clonal strains of hormone-producing pituitary cells. Meth Enzymol Cell Culture 1979;58:527-535.
38. Yamashita S, Slanina S, Kado H, Melmed S: Autoregulation of pituitary growth hormone mRNA in rats bearing transplantable mammosomatotropic pituitary tumors. Endocrinology 1986;118:915-918.
39. Karaplis AC, Yasuda T, Hendy GN, Goltzman D, Banville D: Gene-encoding parathyroid hormone-like peptide: Nucleotide sequence of the rat gene and comparison with the human homologue. Mol Endocrinol 1990;4:441-446.
40. Hongo T, Kupfer J, Enomoto H, Sharifi B, Giannella-Neto D, Forrester JS, Singer FR, Goltzman D, Hendy GN, Pirola C, Fagin JA, Clemens TL: Abundant expression of parathyroid hormone-related primary rat aortic smooth muscle cells accompanies serum-induced proliferation. J Clin Invest 1991;88:1841-1847.
41. Rodan SB, Wesolowski G, Ianacone J, Thiede MA, Rodan GA: Production of parathyroid hormone-like peptide in a human osteosarcoma cell line: stimulation by phorbol esters and epidermal growth factor. J Endocrinol 1989;122:219-227.
42. Kiriyama T, Gillespie MT, Glatz JA, Fukumoto S, Moseley JM, Martin TJ: Transforming growth factor-β stimulation of parathyroid hormone-related peptide (PTHrP): A paracrine regulator? Mol Cell Endocrinol 1993;92:55-62.
43. Welch DR, Fabra A, Nakajima M: Transforming growth factor-β stimulates mammary adeno-carcinoma cell invasion and metastatic potential. Proc Natl Acad Sci USA 1990;87:7678-7682.
44. Lound-Johansen M, Bjerkvig R, Humphrey PA: Effect of epidermal growth factor on glioma cell growth, migration and invasion in vitro. Cancer Res 1990;50:6039-6044.
45. Ikeda K, Lu C, Wein M, Margin M, Broadus AE: Transcriptional regulation of the parathyroid hormone-related peptide gene by glucocorticoids and vitamin D in a human C-cell line. J Biol Chem 1989;264:15743-15746.
46. Gillespie MT, Martin TJ: The parathyroid hormone-related protein gene and its expression. Mol Cell Endocrinol 1994;100:143-147.
47. Haq M, Kremer R, Goltzman D, Rabbani SA: A vitamin D analogue (EB 1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo. J Clin Invest 1993;91:2416-2422.
48. Ushiroda Y, Katakami H, Hirabayashi M, Yonekawa T, Osamura RY, Yuki A, Matsukura S: Increased expression of parathyroid hormone-related protein in the pituitary adenoma of human growth hormone-releasing factor-transgenic rats (abstract 1334). 76th Annu Meet Endocr Soc Anaheim, 1994.
49. Wagner RW, Matteucci MD, Lewis JG, Gutierrez AJ, Moulds C, Froehler BC: Antisense gene inhibition by oligonucleotides containing c-5 propyne pyrimidines. Science 1993;260:1510-1513.
50. Wagner RW: Gene inhibition using antisense oligonucleotides. Nature 1994;372:333-335.
51. Kaiser SM, Laneuville P, Bernier SM, Rhim JS, Kremer R, Goltzman D: Enhanced growth a human keratinocyte cell line induced by antisense RNA for parathyroid hormone-related peptide. J Biol Chem 1992;267:13623-13628.
52. Kaiser SM, Sebag M, Rhim JS, Kremer R, Goltzman D: Antisense-mediated inhibition of parathyroid hormone-related peptide production in a keratinocyte cell line impedes differentiation. Mol Endocrinol 1994;8:139-147.
53. Li X, Drucker DJ: Parathyroid hormone-related peptide is a downstream target for ras and sre activation. J Biol Chem 1994;269:6263-6266.
54. Ejima E, Rosenblatt J D, Massari M, et al: Cell-type-specific transactivation of the parathyroid hormone-related protein gene promoter by the human T-cell leukemia virus type 1 (HTLV-I) tax and HTLV-II tax proteins. Blood 1993;81:1017-1023.
55. Dittmer J, Gegnne A, Gitlin SD, et al: Regulation of parathyroid hormone-related protein (PTHrP) gene expression. Sp1 binds through an inverted CACCC motif and regulates promoter activity in cooperation with Ets1. J Biol Chem 1994;269:21428-21432.
56. Mulligan LM, Kwok JBJ, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L, Ponder MA, Telenium H, Tunnacliffe A, Ponder BA: Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993;363:458-460.
57. Lyons J, Landis CA, Harch G: Two G protein oncogenes in human endocrine tumors. Science 1990;249:635-639.
58. Param J, Duprez L, Sande JV, Cochaux P, Gervy C, Mockel J, Domont J, Vassart G: Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 1993;91:179-184.
59. Fagin JA, Matsuo K, Karmarket A, Chen DL, Tang S-H, Koeffler HP: High prevalence of mutations of the p53 gene in poorly differentiated thyroid carcinomas. J Clin Endocrinol Metab 1993;91:179-184.
60. Yamashita S, Ohtsuru A, Ito M, Ng WY, Villadolid MC, Enomoto H, Usa T, Akino K, Tanigawa K, Tsukazaki T, Ozeki S, Namba H, Ito H, Yoshimura T, Nagataki S: Cytokine expression in pituitary tumors; in Melmed S (ed): Molecular and Clinical Advances in Pituitary Disorders. Los Angeles, Endocrine Research and Education. INC 1993. pp 47-51.
61. Ledwith BJ, Manam S, Kraynak AR, Nichols WW, Bradley MO: Antisense-fos RNA causes partial reversion of the transformed phenotypes induced by the c-Ha-ras oncogene. Mol Cell Biol 1990;10:1545-1555.
62. Holt EH, Vasavada RC, Bander NH, Broadus AE, Philbrick WM: Region-specific methylation of the parathyroid hormone-related peptide gene determines its expression in human renal carcinoma cell lines. J Biol Chem 1993;268:20639-20645.
63. Holt EH, Lu C, Dreyer BE, et al: Regulation of parathyroid hormone-related peptide gene expression by estrogen in GH4C1 rat pituitary cells has the pattern of a primary response gene. J Neurochem 1994;62:1239-1246.
64. Ferrari SL, Rizzoli R, Bonjour JP: Effect of epidermal growth factor on parathyroid hormone-related protein production by mammary epithelial cells. J Bone Miner Res 1994;9:639-644.
65. Watanabe T, Yamaguchi K, Takatsuki K, Osame M, Yoshiba M: Constitutive expression of parathyroid hormone-related protein gene in human T cell leukemia virus type-I cell leukemia patients that can be transactivated by HTLV-I tax gene. J Exp Med 1990;172:759-765.
66. Alsat E, Haziza J, Scippo ML, Frankenne F, Evain-Brion D: Increase in EGF receptor and its mRNA levels by PTH(1-34) and PTHrP(1-34) during differentiation of human trophoblast cells in culture. J Cell Biochem 1993;53:32-42.
67. Karga HJ, Alexander JM, Hedley-Whyte ET, Klibanski A, Jameson JL: Ras mutations in human pituitary tumors. J Clin Endocrinol Metab 1992;74:914-919.
68. Cai WY, Alexander JM, Hedley-Whyte ET, Schethauer BW, Jameson JL, Zervas NT, Klibanski A: Ras mutations in human prolactinomas and pituitary carcinomas. J Clin Endocrinol Metab 1994;78:89-93.
69. Landis C, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L: GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumors. Nature 1989;340:692-696.
70. Lyons J, Landis C, Harsh G, Vallar L, Grunewald K, Feichtinger H, et al: Two G proteins oncogenes in human endocrine tumors. Science 1990;249:655-659.
71. Spada A, Vallar L, Faglia G: G protein oncogenes in pituitary tumors. Trends Endocrinol Metab 1992;3:355-360.
72. Tordjman K, Stern N, Ouakine G, Yossiphov Y, Razon N, Nordenskjold M, et al: Activating mutations of the Gs a-gene in nonfunctioning pituitary tumors. J Clin Endocrinol Metab 1993;77:765-769.
73. Herman V, Fagin JA, Gonsky R, Kovacs K, Melmed S: Clonal origin of pituitary adenomas. J Clin Endocrinol Metab 1990;71:1427-1433.
74. Pei L, Melmed S, Scheithauer B, Kovacs K, Prager D: H-ras mutations in human pituitary carcinoma metastasis. J Clin Endocrinol Metab 1994;78:842-846.
75. Cryns VL, Alexander J, Klibanski A, Arnold A: The retinoblastoma gene in human pituitary tumors. J Clin Endocrinol Metab 1993;77:644-647.
76. Skorski T, Szczlik C, Ratajczak MZ, Malaguarnera L, Gewirtz AM, Calabretta B: Growth factor-dependent inhibition of normal hematopoiesis by N-ras antisense oligonucleotides. J Exp Med 1992;175:743-750.
77. Rian E, Jemtland R, Olstad OK, Endresen MJ, Grasser WA, Thiede MA, Henriksen T, Bucht E, Gautvik KM: Parathyroid hormone related peptide is produced by cultured endothelial cells: A possible role in angiogenesis. Biochem Biophys Res Commun 1994;198:740-747.
78. Mok LLS, Ajiwe E, Martin TJ, Thompson JC, Cooper CW: Parathyroid hormone-related protein relaxes rat gastric smooth muscle and shows cross-desensitization with parathyroid hormone. J Bone Miner Res 1989;4:433-439.
79. Okano K, Wu S, Huang X, Prirola CJ, Juppner H, Abou-Samra A-B, Segre GV, Iwasaki K, Fagin JA, Clemens TL: Parathyroid hormone (PTH)/PTH-related protein (PTHrP) receptor and its messenger ribonucleic acid in rat aortic vascular smooth muscle cells and UMR osteoblast-like cells: Cell-specific regulation by angiotensin-II and PTHrP. Endocrinology 1994;135:1093-1099.
80. Noda M, Rodan GA: Transcriptional regulation of osteoportin production in rat osteoblast-like cells by parathyroid hormone. J Cell Biol 1989;108:713-718.
81. Babich M, Foti LR: E-cadherins identified in osteoblastic cells: Effects of parathyroid hormone and extracellular calcium on locomotion. Life Sci 1994;54:201-208.
82. Hijiya N, Shang J, Ratajczak MZ, Kant A, Deriel K, Herlyn M, Zon G, Gewirtz AM: Biologic and therapeutic significance of MYB expression in human melanoma. Proc Natl Acad Sci USA 1994;91:4499-4503.
83. Kitajima I, Shinohara T, Bilakovics J, Brown DA, Xu X, Nerenberg M: Ablation of transplanted HTLV-1 TAX-transformed tumors in mice by antisense inhibition of NF-kB. Science 1992;258:1792-1795.
84. Akino K, Ohtsuru A, Yano H, Ozeki S, Namba H, Nakashima M, Ito M, Matsumoto T, Yamashita S: Antisense inhibition of parathyroid hormone-related peptide gene expression reduces malignant pituitary tumor progression and metastases in the rat. Cancer Res 1996. in press.